Pharmacogenetics and nicotine addiction treatment (Q36192658)

12 August 2017

1 reference

title

Pharmacogenetics and nicotine addiction treatment (English)

1 reference

12 August 2017

1 reference

1

1 reference

12 August 2017

5

Caryn Lerman

1 reference

12 August 2017

Freda Patterson

4

1 reference

ORCID Public Data File 2021

author name string

Alexandra E Shields

series ordinal

2

1 reference

PubMed ID

16013953

12 August 2017

Wade H Berrettini

series ordinal

3

1 reference

12 August 2017

1 April 2005

1 reference

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

211-223

1 reference

12 August 2017

3

1 reference

Tobacco Cessation: New Challenges, New Opportunities

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies, and suggestions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Randomised controlled trial of nasal nicotine spray in smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Efficacy of a nicotine lozenge for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Treating tobacco dependence: state of the science and new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

A genetic association study of the mu opioid receptor and severe opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Pharmacogenetic investigation of smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Dopamine transporter genotype as a risk factor for obesity in African-American smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Changes in food reward following smoking cessation: a pharmacogenetic investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Genetic case-control association studies in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Population stratification and spurious allelic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Use of unlinked genetic markers to detect population stratification in association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Genome-wide association studies for common diseases and complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Genome-wide association studies: theoretical and practical concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Selective processing of smoking-related cues in current smokers, ex-smokers and never-smokers on the modified Stroop task

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Attentional shifts to smoking cues in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

The challenge of integrating genetic medicine into primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Changes in the scope of care provided by primary care physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Factors influencing health insurers' decisions to cover new genetic technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

The 'new genetics' and primary care: GPs' views on their role and their educational needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Protecting privacy to improve health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Shared decision making and non-directiveness in genetic counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Genetic discrimination and health insurance: an urgent need for reform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

The dopamine D2 receptor gene: a genetic risk factor in substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

D2 and D4 dopamine receptor polymorphisms and personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

A model agreement for genetic research in socially identifiable populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

Smoking by blacks and whites: socioeconomic and demographic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.6.3.211

21 January 2018

Identifiers

DOI

10.1517/14622416.6.3.211

1 reference

12 August 2017

1 reference

PubMed ID

16013953